(MENAFN- Baystreet.ca) Over the next three weeks, Canada's Cannabis 2.0 is expectedto create even more opportunity for CBD companies.In fact, on October 17, 2019, the countrywill legalize edibles, beverages, and topicals just a year after approving driedcannabis flower, oils, and sprays. Analysts at Deloitte already believe Cannabis 2.0 could create a C$2.7billion opportunity.It's alreadyexpected to benefit includes Aurora Cannabis (NYSE:ACB)(TO:ACB), which recentlyannounced its expansion into edibles, vapes, and concentrates. Canopy Growthjust announced at the Barclays 2019 Global Consumer Staples Conference thatCannabis 2.0 would be a major catalyst for the company over the next 12 to 18months. Other top beneficiaries include The Yield Growth Corp. (CSE:BOSS)(OTC:BOSQF), Charlotte's WebHoldings Inc. (CN:CWEB)(OTC:CWBHF), Aphria Inc. (NYSE:APHA)(TO:APHA), GW Pharmaceuticals (NASDAQ:GWPH), and OrganiGram Holdings Inc. (TSX:OGI)(NASDAQ:OGI).
The Yield Growth Corp. (CSE:BOSS)(OTCQB:BOSQF) BREAKING NEWS: The YieldGrowth Corp. just announced that five moreUrban Juve productshave each received aCompliance Certificate completing registration of the products in the EuropeanUnion, bringing the total number of European registered products to eight.The newly approved products includeTerpene-Rich Face Moisturizer with Hemp Oil & Pomegranate Oil for Dry Skin,Terpene-Rich Face Moisturizer with Hemp Oil & Helichrysum Flower Water forOily Skin, Hydrating Body Oil, Nurturing Body Oil and Energizing Body Oil.
Urban Juve is expecting European approval within the monthfor three additional products currently for sale in North America, and it hasbegun the registration process for 4 more products - an all-natural deodorantand Tinted Hemp Oil Lip Therapy in 3 colors. Urban Juve is a hemp-powered skin care line the brings togetherAyurvedic teachings and modern science. It is focused on delivering true rejuvenation from the inside out. Itsnatural, effective products are infused with high quality botanicals, includinghemp root oil which is crafted through its proprietary extraction process.Urban Juve products are targeted to the wellness-conscious consumer, with aprimary target market of Millennials (ages 22 - 37) and a strong secondarymarket of Gen X (ages 38 - 53).
Urban Juve products will be featured in the Vogue BeautyHighlight sections of this year's September, October and November issues of UKVogue, each with an expected audience of 4.1 million readers. Also, Urban Juvewill be featured in UK Vanity Fair's first ever beauty showcase in the November2019 issue.With increasing brandexposure in the UK, Urban Juve is now looking to secure a distribution alliancein the United Kingdom. Urban Juve is building a robust internationaldistribution platform with distribution partners who have access to 44,000retail points of sale.Recently, UrbanJuve announced distribution deals in Canada, Columbia, Brazil, Greece andCyprus. As proposed legislation across the European Union continues to bringcannabis closer to the mainstream, high-end cannabis products are gainingpopularity. With a total population over 508 million, the EU represents massivemarket potential for Urban Juve products.
Other related cannabis industry developmentsinclude:
Charlotte's Web Holdings Inc. (CN:CWEB)(OTC:CWBHF)announced thatTheVitamin Shoppe , an omni-channel, specialty retailer of nutritionalproducts, has commenced selling the new line of Charlotte's Web CBD hempextract-infused CBD gummies in 738 stores across 45 U.S. states. Thisexpands Charlotte's Web product offerings carried by The Vitamin Shoppe toinclude CBD hemp extract oil tinctures, liquid capsules, and now gummies.Charlotte's Web gummies are a popular edible format providing measurableconsumption of convenient bite-sized full-spectrum CBD hemp extract.Charlotte's Web gummies, launched in June ofthis year, are made with whole-plant extract from its prized hemp genetics featuringsynergistic functional ingredients to support specific health related functionsincluding everyday stress, sleep, and recovery from exercise or activelifestyles. "This nationwide pickup of our popular new gummy line by TheVitamin Shoppe is very exciting to report," said Charlotte's Web CEODeanie Elsner. "Working with a trusted retail partner that is dedicated tohelping its customers become their best self, allows us to effectively expandour national footprint giving more Americans retail access to our leading CBDhemp extract wellness products. We are thrilled about The Vitamin Shoppe'sdecision to expand their offering with our new chewable gummies."
Aphria Inc. (NYSE:APHA)(TO:APHA) just announced the launch of its cannabiseducation program ‘ AphriaEducates' . Thisprogram is mandated to educate Canadian adults on responsible and safe use ofall cannabis products legally available now and in the future.The first Aphria Educates event will be a two-city educational panel in conjunctionwith Drugs Free Kids Canada (DFK), a Canadian non-profit organization providingparents with evidence-informed information about youth and substance use whilepromoting frequent, balanced parent-youth discussions about drugs.Entitled AphriaEducates with Drug Free Kids Canada, thepanels will focus on furthering awareness around the potential harms ofcannabis for youth and help parents navigate the ever-evolving Canadian cannabislandscape.The Aphria Educateswith Drugs Free Kids Canada initiative follows the 2018 CharterAgreement entered into by Aphria and DFK solidifying their commitment toongoing cannabis education. "Cannabiseducation is a cornerstone of our Corporate Social Responsibility platform andis paramount in everything we do at Aphria Inc. We are proud to launch Aphria Educates, an engaging programthat is designed to educate on the safe and responsible use of legalcannabis," said Irwin D. Simon. "There is no better partner than Drug Free Kids Canada to help kickoff this first initiative of Aphria Educates, which we believe will deliverimportant information and will encourage necessary dialogue among Canadianparents and their children."
GW PharmaceuticalsPLC (NASDAQ:GWPH) just announced that theEuropean Commission (EC)has approvedthe marketing authorization for EPIDYOLEX for use as adjunctive therapy ofseizures associated with Lennox‑Gastaut syndrome (LGS) or Dravet syndrome, inconjunction with clobazam, for patients 2 years of age and older. The approvalpaves the way for the launch of the medicine across Europe."The approval of EPIDYOLEX marks asignificant milestone, offering patients and their families the first in a newclass of epilepsy medicines and the first and only EMA-approved CBD medicine totreat two severe and life-threatening forms of childhood-onset epilepsy," saidJustin Gover, GW's CEO. "This approval is the culmination of many years ofdedication and collaboration between GW, physicians and the epilepsy community.We believe patients and physicians deserve access to rigorously tested andevaluated cannabis-based medicines, manufactured to the highest standards andapproved by medicines regulators, and we are delighted to be the first to offerthis solution to the epilepsy community."
OrganiGram HoldingsInc. (TSX:OGI)(NASDAQ:OGI) just announced that effective September 6,2019 it has receivedHealthCanada's approvalfor the licensing of 17 additional cultivation rooms underthe Cannabis Regulations. The new cultivation rooms represent approximately15,000 kg/yr1 ofincreased target production capacity. These are the first 17 rooms licensedwithin the Company's Phase 4B expansion and now brings the Company's Monctonfacility to annualized licensed capacity to a target of 76,000 kg1. The licenses are valid until March 27,2020 and subject to terms and conditions. "Once again, we are pleased toreceive licensing approval consistent with our expectations and the streamlinedprocess we have experienced to date. Our Phase 4 facility expansion remains onschedule to meet growing demand and further contribute to efficiencies ofscale," explains Greg Engel, CEO, Organigram.
Legal Disclaimer / Except for the historical informationpresented herein, matters discussed in this article contain forward-lookingstatements that are subject to certain risks and uncertainties that could causeactual results to differ materially from any future results, performance orachievements expressed or implied by such statements. Winning Media which has apartnership with www.MarijuanaStox.com is not registeredwith any financial or securities regulatory authority and does not provide norclaims to provide investment advice or recommendations to readers of thisrelease. For making specific investment decisions, readers should seek theirown advice. Winning Media, which has a partnership with www.MarijuanaStox.com ,is only compensated for its services in the form of cash-based compensation.Pursuant to an agreement between Winning Media (partners of MarijuanaStox.com)and The Yield Growth Corp, Winning Media has been paid four thousand fivehundred dollars for advertising and marketing services for The Yield GrowthCorp. We own ZERO shares of The Yield Growth Corp. Please click here for fulldisclaimer.
Contact Information:
2818047972
MENAFN3009201902120000ID1099066760
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.